Zobrazeno 1 - 10
of 627
pro vyhledávání: '"Poulter, Nr"'
Autor:
Beaney, T, Wang, W, Schlaich, MP, Schutte, AE, Stergiou, GS, Alcocer, L, Alsaid, J, Diaz, AB, Hernandez-Hernandez, R, Ishaq, M, Jozwiak, J, Khan, N, Kiru, G, McCardle, H, Odili, AN, Pyun, WB, Romero, CA, Wang, J, Poulter, NR, MMM Investigators
BACKGROUND: Raised blood pressure (BP) remains the biggest risk factor contributing to the global burden of disease and mortality, despite the COVID-19 pandemic. May Measurement Month (MMM), an annual global screening campaign aims to highlight the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::199423bfedee6154e38486e8133abdca
http://hdl.handle.net/10044/1/105350
http://hdl.handle.net/10044/1/105350
Autor:
Gnanenthiran SR, Borghi C, Burger D, Caramelli B, Charchar F, Chirinos JA, Cohen JB, Cremer A, Di Tanna GL, Duvignaud A, Freilich D, Gommans DHF, Gracia-Ramos AE, Murray TA, Pelorosso F, Poulter NR, Puskarich MA, Rizas KD, Rothlin R, Schlaich MP, Schreinlecher M, Steckelings UM, Sharma A, Stergiou GS, Tignanelli CJ, Tomaszewski M, Unger T, van Kimmenade RRJ, Wainford RD, Williams B, Rodgers A, Schutte AE, COVID‐METARASI Consortium
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 11
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 11, 17
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 11, 17
Background Published randomized controlled trials are underpowered for binary clinical end points to assess the safety and efficacy of renin‐angiotensin system inhibitors (RASi) in adults with COVID‐19. We therefore performed a meta‐analysis to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68acf2a6de99d79d0e7b2a8be5fe97e2
https://hdl.handle.net/11585/899436
https://hdl.handle.net/11585/899436
Autor:
Dzudie, A, Njume, E, Mfekeu, LK, Djomou, A, Ba, H, Ndom, MS, Nkoke, C, Ndongo, S, Boombhi, J, Kamdem, F, Mouandjo, JPD, Mouliom, SA, Kouam, CK, Meli, H, Monkam, Y, Awungia, A, Serah, A, Tantchou, C, Ndjebet, J, Menanga, A, Beaney, T, Clarke, J, Poulter, NR, Kengne, AP, Kingue, S, Cameroon Cardiac Society and MMM Cameroon investigator group
Publikováno v:
European Heart Journal Supplements : Journal of the European Society of Cardiology
B36
B33
B36
B33
The multi-country May Measurement Month (MMM) screening campaign aims to raise awareness on blood pressure (BP) and hypertension in individuals and communities, and measure BP, ideally, of those who had no BP measurement in the preceding year. We her
Autor:
Barbosa, ECD, Feitosa, AM, Bortolotto, LA, Guerra, GM, Filho, JCAF, Cestário, EES, Yugar-Toledo, JC, Pimentel, R, Ferrari, B, Aguiar, R, Barroso, WKS, Eibel, B, Xia, X, Poulter, NR, Beaney, T, Collaborators
Publikováno v:
European Heart Journal Supplements : Journal of the European Society of Cardiology
B32
B30
B32
B30
The aim of this study is to describe the results of the May Month Measurement (MMM) campaign implemented in Brazil, in 2019. Questionnaire data were collected and three measures of blood pressure (BP) were performed. The sample consisted of 13 476 in
Autor:
Alcocer, L, Chavez, A, Gomez-Alvarez, E, Espinosa, C, Pombo, J, Beaney, T, Ster, AC, Poulter, NR, MMM18-Mexico investigators
Publikováno v:
European Heart Journal Supplements : Journal of the European Society of Cardiology
H91
H89
H91
H89
In 2015, arterial hypertension was responsible for 18.1% of the total deaths in Mexico and its mortality rate has increased to 29.9% in the last 6 years. It is currently the main risk factor for preventable premature deaths of adults in the country.
Autor:
Tack, CJ, Jacob, S, Desouza, C, Bain, SC, Buse, JB, Nauck, MA, Petrie, JR, Poulter, NR, Pratley, RE, Stegmann, HVBK, Bosch-Traberg, H, Startseva, E, Zinman, B, LEADER Publication Committee on behalf of the LEADER Trial Investigators
Publikováno v:
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism, 21, 2450-2458
Diabetes, Obesity & Metabolism, 21, 11, pp. 2450-2458
Diabetes, Obesity & Metabolism, 21, 2450-2458
Diabetes, Obesity & Metabolism, 21, 11, pp. 2450-2458
Contains fulltext : 215463.pdf (Publisher’s version ) (Open Access) AIM: Glucagon-like peptide-1 receptor agonist (GLP-1RA) and insulin combination therapy is an effective treatment option for type 2 diabetes, but long-term data are lacking. The ai
Autor:
Mann, JFE, Fonseca, V, Mosenzon, O, Raz, I, Goldman, B, Idorn, T, Von Scholten, BJ, Poulter, NR
Publikováno v:
Circulation
Supplemental Digital Content is available in the text.
Background: LEADER trial (Liraglutide Effect and Action in Diabetes: Evaluation of CV Outcome Results) results demonstrated cardiovascular benefits for patients with type 2 diabetes mellitus
Background: LEADER trial (Liraglutide Effect and Action in Diabetes: Evaluation of CV Outcome Results) results demonstrated cardiovascular benefits for patients with type 2 diabetes mellitus
Autor:
Haj Amor, S, Beaney, T, Saidi, O, Clarke, J, Poulter, NR, Ben Alaya, N, Ben Romdhane, H, MMM Tunisian Working Group
Publikováno v:
B146
B144
European Heart Journal Supplements : Journal of the European Society of Cardiology
B144
European Heart Journal Supplements : Journal of the European Society of Cardiology
We performed a May Measurement Month (MMM) screening campaign among adult volunteers aged 18 years old and over in Tunisia. The objective was to raise awareness, and to estimate the prevalence, awareness, treatment, and control of hypertension, one o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::033b32b702fa0040ea49b20422a54aec
http://hdl.handle.net/10044/1/90577
http://hdl.handle.net/10044/1/90577
Autor:
Amod, A, Buse, JB, McGuire, DK, Pieber, TR, Pop-Busui, R, Pratley, RE, Zinman, B, Hansen, MB, Jia, T, Mark, T, Poulter, NR, DEVOTE Study Group
Publikováno v:
Diabetes & Vascular Disease Research
Aim: To investigate risk factors associated with kidney disorders in patients with type 2 diabetes (T2D) at high cardiovascular (CV) risk. Methods: In DEVOTE, a cardiovascular outcomes trial, 7637 patients were randomised to insulin degludec (deglude
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b396e0681eeeab31837a1a4cc82d02d
http://hdl.handle.net/10044/1/90543
http://hdl.handle.net/10044/1/90543
Autor:
Patil, M, Jose, AP, More, A, Maheshwari, A, Verma, N, Shah, R, Kaur, A, Kaushik, A, Sepat, P, Beaney, T, Clarke, J, Bagadia, L, Jadhav, S, Poulter, NR, Prabhakaran, D
Publikováno v:
B161
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::904b8bedd9ea094f1bb987f23dae56a6
http://hdl.handle.net/10044/1/94864
http://hdl.handle.net/10044/1/94864